A rapidly changing AI industry and still-elevated inflation are among developments investors are facing this year.

Fintel reports that on January 30, 2025, Stifel upgraded their outlook for Edwards Lifesciences (NYSE:EW) from Hold to Buy.

The S&P 500 has had a volatile start to 2025 but has still managed to gain 3.8% year to date as of market close on Jan. 24.

The Federal Reserve's path forward on interest rates remains highly uncertain. Check out the three-fund portfolio that should ...

Rate My Portfolio: our reader wants to maximise returns but keep deposit money accessible ...

There are many different investing strategies. One to consider is buying large, diversified, and liquid ETFs with solid ...

2025 is anticipated to be a bullish year for the stock market, with more performance potential for small- and mid-cap ...